Roivant Sciences Ratios (2020-2025) | ROIV

1Y3Y5Y7Y10YAll
Download Data
Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin 88.58%45.96%88.10%90.41%54.38%94.31%60.04%70.95%78.97%80.51%93.89%98.73%97.33%94.77%97.13%92.90%92.93%64.98%
EBT Margin -428.68%-3,989.95%-4,796.89%-1,305.56%-1,610.35%-1,257.33%-8,098.75%-2,503.44%-2,240.66%-1,508.01%-6,617.49%33,116.21%-245.81%-5,014.15%-2,600.50%-12,408.39%-10,123.74%-14,525.71%
EBIT Margin -7,262.25%-11,832.28%-4,505.57%-1,995.95%-4,893.32%-1,010.73%-6,536.44%-2,240.21%-2,217.20%-1,278.27%-5,863.24%32,948.56%-1,279.54%-7,636.04%-3,042.59%-13,130.05%-19,492.87%-16,966.13%
EBITDA Margin -7,262.25%-11,832.28%-4,505.57%-1,995.95%-4,893.32%-1,010.73%-6,536.44%-2,240.21%-2,217.20%-1,278.27%-5,863.24%32,948.56%-1,279.54%-7,636.04%-3,042.59%-13,130.05%-19,492.87%-16,966.13%
Operating Margin -7,262.25%-11,832.28%-4,505.57%-1,995.95%-4,893.32%-1,010.73%-6,536.44%-2,240.21%-2,217.20%-1,278.27%-5,863.24%32,948.56%-1,279.54%-7,636.04%-3,042.59%-13,130.05%-19,492.87%-16,966.13%
Net Margin -506.15%-4,043.69%-4,792.99%-1,306.76%-1,613.21%-1,257.49%-8,191.34%-2,520.71%-2,257.19%-1,516.12%-2,370.50%-376.01%1,115.06%-962.75%3,626.30%
FCF Margin -7,073.16%-3,146.45%-1,855.32%-881.94%-2,224.37%-6,009.28%-1,537.79%-3,960.67%-1,157.67%-5,392.05%-4,227.25%-2,425.46%-5,984.40%-7,437.06%-9,604.52%-12,317.76%-9,582.24%
Efficiency
Inventory Average 3.49M4.57M5.07M20.25M34.62M
Assets Average 2,522.19M2,778.80M2,951.14M2,692.25M2,592.76M2,407.97M2,209.25M2,296.28M2,263.12M2,101.09M4,689.11M7,267.58M6,859.47M6,351.24M5,999.19M5,614.64M5,234.77M5,047.60M5,143.98M
Equity Average 1,998.43M2,192.87M2,337.84M2,143.10M1,897.17M1,634.77M1,470.64M1,517.36M1,470.86M1,329.89M3,955.11M6,516.56M6,171.91M5,737.66M5,558.01M5,361.58M5,001.55M4,810.68M4,889.84M
Invested Capital 2,209.79M2,143.69M2,628.28M2,451.30M2,248.97M2,139.11M1,890.21M1,802.26M1,983.10M1,719.21M1,715.08M6,987.92M6,879.12M6,207.00M5,580.04M5,535.97M5,187.20M4,815.91M4,805.46M4,974.22M
Asset Utilization Ratio 0.010.010.020.020.020.020.020.010.020.020.010.010.000.000.000.000.000.000.00
Leverage & Solvency
Interest Coverage Ratio -108.08-33.69-44.76-31.02-23.13542.93-7.63
Debt to Equity 0.080.100.080.090.020.020.130.140.120.160.160.030.030.03
Debt Ratio 0.070.080.060.070.010.010.090.090.080.100.100.030.030.03
Equity Ratio 0.790.800.780.800.790.680.680.650.670.620.640.900.890.910.900.960.950.960.950.95
Times Interest Earned -108.08-33.69-44.76-31.02-23.13542.93-7.63
Valuation
Enterprise Value -1891.02M-1768.49M-2112.47M-1835.66M-1682.30M-1574.89M-1250.44M-1055.82M-1232.00M-1010.68M-1031.13M-6205.18M-6015.01M-5240.02M-4959.57M-4800.01M-4387.30M-4032.88M-3942.71M-3825.01M
Return Ratios
Return on Sales -5.06%-40.44%-47.93%-38.97%-13.07%-16.13%-12.57%-13.74%-81.91%-25.21%-22.57%-31.11%-15.16%-23.71%-3.76%-11.58%11.15%-9.63%36.26%17.36%18.13%25.63%
Return on Capital Employed -0.30%-0.51%-0.48%-0.60%-0.69%-0.60%-0.60%-0.63%0.96%0.68%0.77%0.75%-0.20%-0.25%-0.24%
Return on Invested Capital -0.32%-0.53%-0.53%-0.63%-0.75%-0.65%-0.66%-0.67%0.97%0.69%0.75%0.79%-0.20%-0.25%-0.25%
Return on Assets -0.17%-0.22%-0.21%-0.24%-0.34%-0.41%-0.48%-0.46%-0.45%-0.38%-0.10%-0.07%-0.01%0.00%0.06%0.07%0.05%0.06%
Return on Equity -0.22%-0.27%-0.27%-0.30%-0.47%-0.60%-0.72%-0.70%-0.70%-0.60%-0.12%-0.07%-0.01%0.00%0.07%0.07%0.06%0.07%